Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FTXH vs LYFIX overlap: 21% of top holdings shared

Bottom line

How much do FTXH and LYFIX overlap?

21% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 25.7% of FTXH's assets and 25.1% of LYFIX's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

FTXHLYFIX
Weight overlap (top 25)21%
Shared holdings8
Weight in shared holdings25.7%25.1%
Total positions5162
Expense ratio0.6%1.41%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings FTXH and LYFIX have in common

Holding% of FTXH% of LYFIXOverlap
Abbvie Inc ABBV7.39%1.95%1.95%
Biogen Inc BIIB3.84%1.80%1.80%
Vertex Pharmaceuticals Inc VRTX3.41%5.33%3.41%
Amgen Inc AMGN3.18%1.83%1.83%
Gilead Sciences Inc GILD2.89%5.53%2.89%
Incyte Corp INCY2.39%3.51%2.39%
Neurocrine Biosciences Inc NBIX1.37%3.51%1.37%
Halozyme Therapeutics Inc HALO1.21%1.58%1.21%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FTXH

  1. Eli Lilly & Company — 7.77%
  2. Merck & Company Inc — 7.07%
  3. Johnson & Johnson — 6.96%
  4. Bristol-myers Squibb Company — 6.29%
  5. Viatris Inc — 3.62%
  6. Cardinal Health Inc — 3.53%
  7. Pfizer Inc — 2.97%
  8. United Therapeutics Corp — 2.72%
  9. Regeneron Pharmaceuticals Inc — 2.72%
  10. Jazz Pharmaceuticals Plc — 2.49%
  11. Illumina Inc — 1.98%
  12. Zoetis Inc — 1.87%
  13. Exelixis Inc — 1.72%
  14. Charles River Laboratories International Inc — 1.49%
  15. Medpace Holdings Inc — 1.41%

Only in LYFIX

  1. Astrazeneca Plc — 4.63%
  2. First American Funds Inc — 4.26%
  3. Roivant Sciences Ltd — 3.67%
  4. Argenx Se — 3.59%
  5. Axsome Therapeutics Inc — 3.43%
  6. Apogee Therapeutics Inc — 3.28%
  7. Ionis Pharmaceuticals Inc — 2.62%
  8. Ascendis Pharma A/s — 2.62%
  9. Insmed Inc — 2.60%
  10. Protagonist Therapeutics Inc — 2.41%
  11. Personalis Inc — 2.27%
  12. Rhythm Pharmaceuticals Inc — 2.25%
  13. Jazz Pharmaceuticals Plc — 1.87%
  14. Catalyst Pharmaceuticals Inc — 1.59%
  15. Meiragtx Holdings Plc — 1.58%

Asset mix

Asset typeFTXHLYFIX
Stocks99.9%95.8%
Cash & short-term funds0.1%4.3%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryFTXHLYFIX
US95.6%76.0%
NL—4.7%
GB—4.6%
IE3.8%2.4%
BM0.6%3.7%
FR—2.8%
DK—2.6%
KY—1.6%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do FTXH and LYFIX overlap?
About 21% by weight. 8 securities appear in both funds' top 25 holdings; they make up 25.7% of FTXH's assets and 25.1% of LYFIX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do FTXH and LYFIX have in common?
The largest shared holdings are Vertex Pharmaceuticals Inc, Gilead Sciences Inc, Incyte Corp, Abbvie Inc, Amgen Inc.
Should I own both FTXH and LYFIX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, FTXH or LYFIX?
LYFIX is broader, with 62 positions versus 51 for FTXH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.